Lipoprotein (a) in familial hypercholesterolaemia
PN Durrington, B Bashir, D Bhatnagar… - Current opinion in …, 2022 - journals.lww.com
Inheritance of familial hypercholesterolaemia undoubtedly increases the likelihood that
lipoprotein (a) will be raised. However, in familial hypercholesterolaemia when ASCVD …
lipoprotein (a) will be raised. However, in familial hypercholesterolaemia when ASCVD …
Lipoprotein (a) as part of the diagnosis of clinical familial hypercholesterolemia
A Langsted, BG Nordestgaard - Current Atherosclerosis Reports, 2022 - Springer
Abstract Purpose of Review Individuals with familial hypercholesterolemia have very high
risk of cardiovascular disease due to lifelong elevations in LDL cholesterol. Elevated …
risk of cardiovascular disease due to lifelong elevations in LDL cholesterol. Elevated …
High lipoprotein (a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
A Langsted, PR Kamstrup, M Benn… - The lancet Diabetes & …, 2016 - thelancet.com
Background The reason why lipoprotein (a) concentrations are raised in individuals with
clinical familial hypercholesterolaemia is unclear. We tested the hypotheses that high …
clinical familial hypercholesterolaemia is unclear. We tested the hypotheses that high …
Lipoprotein (a): genetic marker for atherosclerosis?
WC Breckenridge - CMAJ: Canadian Medical Association Journal, 1990 - ncbi.nlm.nih.gov
In lipid composition lipoprotein (a), or Lp (a), resembles low-density lipoprotein (LDL), but Lp
(a) is denser and larger.'" 2 Its unique immunologic characteristics are due to apolipoprotein …
(a) is denser and larger.'" 2 Its unique immunologic characteristics are due to apolipoprotein …
Familial hypercholesterolemia and lipoprotein (a): two partners in crime?
R Alonso, R Argüeso, P Álvarez-Baños… - Current Atherosclerosis …, 2022 - Springer
Abstract Purpose of Review Familial hypercholesterolemia is a high cardiovascular risk
disorder. We will review the role of lipoprotein (a) in cardiovascular risk and in aortic valve …
disorder. We will review the role of lipoprotein (a) in cardiovascular risk and in aortic valve …
Lipoprotein (a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia
DT Holmes, BA Schick, KH Humphries… - Clinical …, 2005 - academic.oup.com
Background: The role of lipoprotein (a)[Lp (a)] as a predictor of cardiovascular disease
(CVD) in patients with heterozygous familial hypercholesterolemia (HFH) is unclear. We …
(CVD) in patients with heterozygous familial hypercholesterolemia (HFH) is unclear. We …
Lipoprotein (a) in homozygous familial hypercholesterolemia
HG Kraft, A Lingenhel, FJ Raal… - … , and vascular biology, 2000 - Am Heart Assoc
Lipoprotein (a)[Lp (a)] is a quantitative genetic trait that in the general population is largely
controlled by 1 major locus—the locus for the apolipoprotein (a)[apo (a)] gene. Sibpair …
controlled by 1 major locus—the locus for the apolipoprotein (a)[apo (a)] gene. Sibpair …
Lipoprotein (a) levels in patients with homozygous familial hypercholesterolaemia
G Miltiadous, V Tsimihodimos… - …, 2001 - atherosclerosis-journal.com
Familial hypercholesterolaemia (FH) is a clinical syndrome that results from mutations in the
low-density lipoprotein receptor (LDLR) gene. The worldwide prevalence of homozygosity is …
low-density lipoprotein receptor (LDLR) gene. The worldwide prevalence of homozygosity is …
Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
M Seed, F Hoppichler, D Reaveley… - … England Journal of …, 1990 - Mass Medical Soc
Familial hypercholesterolemia carries a marked increase in the risk of coronary heart
disease (CHD), but there is considerable variation between individuals in susceptibility to …
disease (CHD), but there is considerable variation between individuals in susceptibility to …
Lipoprotein (a): Knowns, unknowns and uncertainties
M Ruscica, CR Sirtori, A Corsini, GF Watts… - Pharmacological …, 2021 - Elsevier
Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …
which are reviewed in the present article. Since the standard immunoassays for measuring …